BE498022A - - Google Patents
Info
- Publication number
- BE498022A BE498022A BE498022DA BE498022A BE 498022 A BE498022 A BE 498022A BE 498022D A BE498022D A BE 498022DA BE 498022 A BE498022 A BE 498022A
- Authority
- BE
- Belgium
- Prior art keywords
- motor
- shutter
- light
- patient
- light source
- Prior art date
Links
- 239000003990 capacitor Substances 0.000 claims description 20
- SNIOPGDIGTZGOP-UHFFFAOYSA-N 1,2,3-propanetrioltrinitrate Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 claims description 15
- 229940014995 Nitroglycerin Drugs 0.000 claims description 15
- 239000000006 Nitroglycerin Substances 0.000 claims description 15
- 229960003711 glyceryl trinitrate Drugs 0.000 claims description 15
- 239000003814 drug Substances 0.000 claims description 11
- 229940079593 drugs Drugs 0.000 claims description 10
- 210000004204 Blood Vessels Anatomy 0.000 claims description 9
- 230000004397 blinking Effects 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 5
- 210000002216 Heart Anatomy 0.000 claims description 4
- 238000002844 melting Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 230000001360 synchronised Effects 0.000 claims description 4
- 210000004369 Blood Anatomy 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 210000000748 cardiovascular system Anatomy 0.000 claims description 3
- 238000005259 measurement Methods 0.000 claims description 3
- 230000004048 modification Effects 0.000 claims description 3
- 238000006011 modification reaction Methods 0.000 claims description 3
- 230000024883 vasodilation Effects 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 2
- 206010047163 Vasospasm Diseases 0.000 description 25
- 206010002660 Anoxia Diseases 0.000 description 18
- 241000976983 Anoxia Species 0.000 description 18
- 230000004927 fusion Effects 0.000 description 16
- 201000010238 heart disease Diseases 0.000 description 13
- 208000004981 Coronary Disease Diseases 0.000 description 8
- 201000008739 coronary artery disease Diseases 0.000 description 8
- 201000002053 hypertensive heart disease Diseases 0.000 description 7
- 210000003169 Central Nervous System Anatomy 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 5
- 230000002159 abnormal effect Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000000304 vasodilatating Effects 0.000 description 5
- 210000001525 Retina Anatomy 0.000 description 4
- 210000003491 Skin Anatomy 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 4
- 210000004556 Brain Anatomy 0.000 description 3
- 210000003414 Extremities Anatomy 0.000 description 3
- 230000000271 cardiovascular Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000001809 detectable Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000002028 premature Effects 0.000 description 3
- 210000001519 tissues Anatomy 0.000 description 3
- 230000000261 vasodilator Effects 0.000 description 3
- 239000003071 vasodilator agent Substances 0.000 description 3
- 238000004804 winding Methods 0.000 description 3
- 208000008787 Cardiovascular Disease Diseases 0.000 description 2
- 210000004351 Coronary Vessels Anatomy 0.000 description 2
- 210000004165 Myocardium Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000001631 hypertensive Effects 0.000 description 2
- 230000002093 peripheral Effects 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 208000007502 Anemia Diseases 0.000 description 1
- 206010002383 Angina pectoris Diseases 0.000 description 1
- 239000010755 BS 2869 Class G Substances 0.000 description 1
- BWFPGXWASODCHM-UHFFFAOYSA-N Copper monosulfide Chemical compound [Cu]=S BWFPGXWASODCHM-UHFFFAOYSA-N 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- 206010052895 Coronary artery insufficiency Diseases 0.000 description 1
- 229920005479 Lucite® Polymers 0.000 description 1
- 210000002418 Meninges Anatomy 0.000 description 1
- 210000002460 Muscle, Smooth Anatomy 0.000 description 1
- 208000010125 Myocardial Infarction Diseases 0.000 description 1
- 206010056697 Tissue anoxia Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000000903 blocking Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- CETPSERCERDGAM-UHFFFAOYSA-N ceric oxide Chemical compound O=[Ce]=O CETPSERCERDGAM-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000002107 myocardial Effects 0.000 description 1
- 229910052754 neon Inorganic materials 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon(0) Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 230000000069 prophylaxis Effects 0.000 description 1
- 230000002285 radioactive Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 230000002455 vasospastic Effects 0.000 description 1
- 230000003313 weakening Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
- A61B5/161—Flicker fusion testing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hospice & Palliative Care (AREA)
- Pathology (AREA)
- Developmental Disabilities (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Social Psychology (AREA)
- Physics & Mathematics (AREA)
- Child & Adolescent Psychology (AREA)
- Biophysics (AREA)
- Educational Technology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE498022A true BE498022A (it) |
Family
ID=140820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE498022D BE498022A (it) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE498022A (it) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2471769A1 (fr) * | 1979-12-20 | 1981-06-26 | Inst Nat Sante Rech Med | Dispositif de stimulation pour l'examen du champ visuel |
-
0
- BE BE498022D patent/BE498022A/fr unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2471769A1 (fr) * | 1979-12-20 | 1981-06-26 | Inst Nat Sante Rech Med | Dispositif de stimulation pour l'examen du champ visuel |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5401966A (en) | Spectrophotometric sensor assembly including a microlamp | |
| EP0465359B1 (fr) | Système de radiodiagnostic pour examen angiographique avec dispositif automatique de suivi d'embole | |
| EP0036095B1 (fr) | Dispositif d'électrode pour mesurer des potentiels électriques de l'oeil | |
| EP0170551B1 (fr) | Dispositif radiologique à asservissement en position de foyer | |
| EP0965306A1 (fr) | Dispositif de détermination de phases respiratoires du sommeil d'un utilisateur | |
| JPS58501310A (ja) | 肺の二酸化炭素ガス分析器 | |
| JPH11506652A (ja) | アクティブ・パルス血液成分監視システム | |
| EP0910286A1 (en) | Optical method and device for determining blood glucose levels | |
| EP0473296A2 (en) | Filter for computed tomography system | |
| EP1382298A1 (en) | X-ray computed tomography apparatus with support system for setting scan conditions | |
| EP0323322B1 (fr) | Dispositif pour mesurer le temps de modification de l'état physique d'un milieu fluide | |
| EP0341143A1 (fr) | Dispositif et procédé de tomographie à grande cadence d'acquisition | |
| EP0721110B1 (fr) | Dispositif capteur délivrant notamment un signal représentatif de la respiration d'un patient | |
| BE498022A (it) | ||
| WO2002085455A1 (fr) | Dispositif de pilotage d'une unite d'imagerie anatomique ou d'une unite de radiotherapie | |
| EP0029793A1 (fr) | Appareillage pour le contrôle des séances d'hémodialyse | |
| FR2565092A1 (fr) | Scanographe comportant un faisceau en eventail rotatif et une couronne de detecteurs non rotative | |
| WO1991014399A1 (fr) | Papillometre | |
| EP0600963B1 (fr) | Materiel de test d'acuite visuelle et/ou de sensibilite aux contrastes spatiaux chez l'homme, dispositif et procede de fabrication correspondants | |
| FR2782629A1 (fr) | Procede d'amelioration de la qualite d'une image fluoroscopique visualisee de facon permanente a l'issue d'une sequence d'acquisition d'images en fluoroscopie cardiaque pulsee | |
| Schmitz et al. | Performance characteristics of silicon photodiode (SiPD)-based instrument for fast functional optical tomography | |
| EP0431989A1 (fr) | Appareil de radiologie avec filtre d'homogénéisation | |
| FR2657488A1 (fr) | Equipement de radiologie multimode a commutation rapide. | |
| US2676512A (en) | Apparatus for detecting vasospasm | |
| FR2476475A1 (fr) | Perfectionnement des tomodensitometres |